Glenmark Expects ‘Strong Year’ With ‘First’ EU Spiriva Rival Imminent
Signed Licensing Deal For Tiotropium Bromide In 2018
Glenmark said it would continue to deliver new respiratory products in Europe moving forward as the Indian firm lines up what it believes will be the first generic version of Boehringer Ingelheim’s Spiriva Handihaler.
